An AllTrials project

NCT05605964: An ongoing trial by Myovant Sciences GmbH

This trial is ongoing. It must report results 3 years, 3 months from now.

Full data

Full entry on ClinicalTrials.gov NCT05605964
Title Relugolix Versus Leuprolide in Patients With Prostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (REPLACE-CV)
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 25, 2023
Completion date Feb. 28, 2027
Required reporting date Feb. 28, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None